NORFLUNIX INJECTION
NORFLUNIX INJECTION
Suspended
- Flunixin meglumine
Product identification
Medicine name:
NORFLUNIX INJECTION
NORFLUNIX 50 mg/ml SOLUCION INYECTABLE PARA PORCINO
Active substance:
- Flunixin meglumine
Target species:
-
Pig
Route of administration:
-
Intramuscular use
Product details
Active substance and strength:
-
Flunixin meglumine82.90/milligram(s)1.00millilitre(s)
Pharmaceutical form:
-
Solution for injection
Withdrawal period by route of administration:
-
Intramuscular use
- Pig
-
Meat and offal24day
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QM01AG90
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Suspended
Authorised in:
-
Spain
Package description:
- box containing 1 vial of 250 ml
- box containing 1 vial of 100 ml
- box containing 1 vial of 50 ml
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Norbrook Laboratories (Ireland) Limited
Marketing authorisation date:
Manufacturing sites for batch release:
- Norbrook Laboratories Limited
- Norbrook Laboratories (Ireland) Limited
Responsible authority:
- (AEMPS)
Authorisation number:
- 1493 ESP
Date of authorisation status change:
Reference member state:
-
Spain
Procedure number:
- ES/V/0121/001
Concerned member states:
-
Greece
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
English (PDF)
Download Published on: 5/04/2023
Spanish (PDF)
Published on: 2/02/2024
How useful was this page?:
